A new daily pill to help with weight loss has been approved by the U.S. Food and Drug Administration (FDA), and it moved ...

Key Takeaways Exercise may help repair a protective barrier around the brainA liver protein associated with exercise helped ...

Use of blockbuster anti-obesity drugs like Wegovy and Zepbound is growing, with about 1 in 8 adults in the U.S. saying they ...

What if you could get the mental health benefits of exercise… without working out? Scientists are exploring “exercise mimetics,” compounds that may activate the same powerful brain-boosting signals ...

The U.S. Food and Drug Administration on Wednesday approved a second oral GLP-1 medication, giving adults eligible for weight ...

Lilly says Foundayo was approved to treat obesity and can lead to long-term weight loss, alongside diet and exercise.

The daily pill, called Foundayo, could make it easier for more people to lose weight.

Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill ...

This week the U.S. Food and Drug Administration approved a second GLP-1 pill for weight loss. The drug, called Foundayo, ...

AN EXERCISE pill that mimics a workout to build muscle and burn fat has entered human patient trials for the first time. A group of 10 overweight men have begun an eight-week test of the once-a-day ...

By Leah Douglas and Christy Santhosh April 1 (Reuters) - The U.S. FDA on Wednesday approved Eli Lilly's weight-loss pill, ...